Advertisement
Advertisement
U.S. markets open in 2 hours 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Reckitt Benckiser Group plc (RBGLY)

Other OTC - Other OTC Delayed Price. Currency in USD
14.02-0.01 (-0.09%)
At close: 03:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close14.03
Open13.91
Bid0.00 x 0
Ask0.00 x 0
Day's Range13.83 - 14.05
52 Week Range12.71 - 17.59
Volume300,135
Avg. Volume1,064,204
Market Cap50.161B
Beta (5Y Monthly)0.17
PE Ratio (TTM)13.74
EPS (TTM)1.02
Earnings DateN/A
Forward Dividend & Yield0.44 (3.11%)
Ex-Dividend DateAug 05, 2022
1y Target Est17.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RBGLY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • RECKITT BENCKISER GROUP PLC SPO
    Analyst Report: Reckitt Benckiser Group plcReckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
    Rating
    Fair Value
    Economic Moat
    14 days agoMorningstar
View more
Advertisement
Advertisement